ESMO-Magnitude of Clinical Benefit Scale (MCBS) group
Click here to listen to the Podcast
Main Author: | Teresa Amaral |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | ESMO Open |
Online Access: | https://esmoopen.bmj.com/content/4/5/e000594.full |
Similar Items
-
Choosing PD-1 Inhibitors in Oncology Setting, Left or Right?—Lessons From Value Assessment With ASCO-VF and ESMO-MCBS
by: Qian Jiang, et al.
Published: (2020-12-01) -
Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
by: Fatima Cardoso, et al.
Published: (2020-10-01) -
Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?
by: Adela Rodriguez, et al.
Published: (2021-02-01) -
Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1
by: Elisabeth G E de Vries, et al.
Published: (2020-10-01) -
Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
by: Igor Aurer, et al.
Published: (2020-08-01)